R. Preston Mason

3.8k total citations · 1 hit paper
74 papers, 2.5k citations indexed

About

R. Preston Mason is a scholar working on Nutrition and Dietetics, Surgery and Biochemistry. According to data from OpenAlex, R. Preston Mason has authored 74 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Nutrition and Dietetics, 39 papers in Surgery and 22 papers in Biochemistry. Recurrent topics in R. Preston Mason's work include Fatty Acid Research and Health (45 papers), Lipoproteins and Cardiovascular Health (22 papers) and Eicosanoids and Hypertension Pharmacology (20 papers). R. Preston Mason is often cited by papers focused on Fatty Acid Research and Health (45 papers), Lipoproteins and Cardiovascular Health (22 papers) and Eicosanoids and Hypertension Pharmacology (20 papers). R. Preston Mason collaborates with scholars based in United States, France and Canada. R. Preston Mason's co-authors include Samuel Sherratt, Deepak L. Bhatt, Robert F. Jacob, Peter Libby, John Nelson, Kenneth M. Borow, Yoshiko Mizuno, Michael Miller, Eliot A. Brinton and Tadeusz Maliñski and has published in prestigious journals such as Science, Circulation and Journal of the American College of Cardiology.

In The Last Decade

R. Preston Mason

68 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid

2020 274 citations R. Preston Mason, Peter Libby et al. Arteriosclerosis Thrombosis and Vascular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Preston Mason United States	28	1.1k	1.0k	614	548	507	74	2.5k
Rebecca A. Juliano United States	18	1.2k 1.1×	1.5k 1.5×	617 1.0×	898 1.6×	1.1k 2.2×	40	3.1k
Rene A. Braeckman United States	24	770 0.7×	708 0.7×	372 0.6×	322 0.6×	510 1.0×	63	1.9k
Yuichi Ishikawa Japan	23	1.8k 1.6×	1.3k 1.3×	894 1.5×	791 1.4×	1.1k 2.1×	81	4.0k
Montserrat Cofán Spain	29	674 0.6×	802 0.8×	153 0.2×	399 0.7×	471 0.9×	100	2.3k
S. Colli Italy	28	648 0.6×	857 0.8×	273 0.4×	597 1.1×	320 0.6×	104	2.7k
Sven Fischer Germany	30	1.9k 1.7×	1.1k 1.0×	1.1k 1.7×	327 0.6×	905 1.8×	87	4.3k
Marit S. Nenseter Norway	28	570 0.5×	676 0.7×	179 0.3×	223 0.4×	303 0.6×	57	2.0k
Neil S. Shachter United States	22	399 0.4×	802 0.8×	227 0.4×	557 1.0×	859 1.7×	32	2.3k
Catherine Calzada France	21	510 0.5×	333 0.3×	328 0.5×	234 0.4×	266 0.5×	57	1.5k
Arne Nordøy Norway	37	1.8k 1.7×	1.1k 1.1×	762 1.2×	674 1.2×	769 1.5×	146	3.8k

Countries citing papers authored by R. Preston Mason

Since Specialization

Citations

This map shows the geographic impact of R. Preston Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Preston Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Preston Mason more than expected).

Fields of papers citing papers by R. Preston Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Preston Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Preston Mason. The network helps show where R. Preston Mason may publish in the future.

Co-authorship network of co-authors of R. Preston Mason

This figure shows the co-authorship network connecting the top 25 collaborators of R. Preston Mason. A scholar is included among the top collaborators of R. Preston Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Preston Mason. R. Preston Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhatt, Deepak L., Robert P. Giugliano, Philippe Gabríel Steg, et al.. (2025). Benefit of icosapent ethyl across types and sizes of myocardial infarction in REDUCE-IT. European Journal of Preventive Cardiology.

Aggarwal, Rahul, Deepak L. Bhatt, Philippe Gabríel Steg, et al.. (2025). Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial. Journal of the American Heart Association. 14(5). e038656–e038656. 2 indexed citations

Kaur, Gurleen, R. Preston Mason, Philippe Gabríel Steg, & Deepak L. Bhatt. (2024). Omega-3 fatty acids for cardiovascular event lowering. European Journal of Preventive Cardiology. 31(8). 1005–1014. 16 indexed citations

Sherratt, Samuel, R. Preston Mason, Peter Libby, & Deepak L. Bhatt. (2024). “A Time to Tear Down and a Time to Mend”: The Role of Eicosanoids in Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 44(11). 2258–2263. 4 indexed citations

Sherratt, Samuel, et al.. (2024). Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation. Journal of the American Heart Association. 13(14). e034076–e034076. 11 indexed citations

Sherratt, Samuel, R. Preston Mason, Peter Libby, Philippe Gabríel Steg, & Deepak L. Bhatt. (2023). Do patients benefit from omega-3 fatty acids?. Cardiovascular Research. 119(18). 2884–2901. 35 indexed citations

Ridker, Paul M., Nader Rifai, Jean MacFadyen, et al.. (2022). Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy. Circulation. 146(5). 372–379. 80 indexed citations

Sherratt, Samuel, Peter Libby, Matthew J. Budoff, Deepak L. Bhatt, & R. Preston Mason. (2022). Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues. Current Atherosclerosis Reports. 25(1). 1–17. 70 indexed citations

Mason, R. Preston, et al.. (2021). EICOSAPENTAENOIC ACID (EPA) INCREASES HEME OXYGENASE-1 EXPRESSION IN ENDOTHELIAL CELLS UNDER CONDITIONS OF INFLAMMATION UNLIKE DOCOSAHEXAENOIC ACID (DHA). Journal of the American College of Cardiology. 77(18). 1829–1829. 2 indexed citations

10.

Sherratt, Samuel, et al.. (2021). EPA and DHA containing phospholipids have contrasting effects on membrane structure. Journal of Lipid Research. 62. 100106–100106. 50 indexed citations

11.

Wang, Xiaowen, Deepak L. Bhatt, Michael Miller, et al.. (2021). ICOSAPENT ETHYL REDUCES ISCHEMIC EVENTS IN PATIENTS WITH HIGH TRIGLYCERIDES AND LOW HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS: REDUCE-IT HIGH TG/LOW HDL-C ANALYSES. Journal of the American College of Cardiology. 77(18). 155–155. 2 indexed citations

12.

Mason, R. Preston & Robert H. Eckel. (2021). Is there a role for omega-3 fatty acids in cardiovascular disease risk reduction?. EClinicalMedicine. 39. 101096–101096. 5 indexed citations

13.

Cutfield, Wayne S., José G. B. Derraik, Matire Harwood, et al.. (2020). Double-blind RCT of fish oil supplementation in pregnancy and lactation to improve the metabolic health in children of mothers with overweight or obesity during pregnancy: study protocol. BMJ Open. 10(12). e041015–e041015. 1 indexed citations

14.

Mason, R. Preston, et al.. (2019). Progressive LDL Reduction to Very Low Levels Improves Dimeric Nitric Oxide Synthase, Nitric Oxide Bioavailability and Reduces Peroxynitrite in Endothelial Cells during Hyperglycemia. American Journal of Pharmacology and Toxicology. 14(1). 7–16. 5 indexed citations

15.

Sherratt, Samuel & R. Preston Mason. (2018). Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction. Chemistry and Physics of Lipids. 212. 73–79. 75 indexed citations

16.

Brinton, Eliot A. & R. Preston Mason. (2017). Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA). Lipids in Health and Disease. 16(1). 23–23. 58 indexed citations

17.

Mason, R. Preston, et al.. (2015). The Role of Military Medical Services in Future Epidemic Influenza. American Review of Respiratory Disease.

18.

Mason, R. Preston & Robert F. Jacob. (2014). Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(2). 502–509. 59 indexed citations

19.

Mizuno, Yoshiko, Robert F. Jacob, & R. Preston Mason. (2011). Inflammation and the Development of Atherosclerosis. Journal of Atherosclerosis and Thrombosis. 18(5). 351–358. 128 indexed citations

20.

Geng, Yong-Jian, et al.. (2001). 7-Ketocholesterol forms crystalline domains in model membranes and murine aortic smooth muscle cells. Atherosclerosis. 159(1). 125–135. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact